LY3143921 structure
|
Common Name | LY3143921 | ||
---|---|---|---|---|
CAS Number | 1627696-53-0 | Molecular Weight | 327.319 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C16H14FN5O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of LY3143921LY3143921 (LY-3143921) is an orally available, potent, selective inhibitor of Cdc7 kinase inhibitor, inhibits CDC7/DBF4 I and pMCM2 (S53) with IC50 values of 3.3 nM and 290 nM, respectively. Solid Tumors Phase 1 Clinical |
Name | LY3143921 |
---|
Description | LY3143921 (LY-3143921) is an orally available, potent, selective inhibitor of Cdc7 kinase inhibitor, inhibits CDC7/DBF4 I and pMCM2 (S53) with IC50 values of 3.3 nM and 290 nM, respectively. Solid Tumors Phase 1 Clinical |
---|---|
References | References View Related Products by Target Cyclin-dependent Kinase (CDK) Solid Tumors |
Molecular Formula | C16H14FN5O2 |
---|---|
Molecular Weight | 327.319 |